Glycaemic control goal attainment among type 2 diabetic patients who initiated oral combination therapy in Europe

被引：0
|
作者：
Krishnarajah, G.
Alvarez-Guisasola, F.
Povedano, S. Tofe
Zhang, Q.
Pulfer, G. Nocea
Yin, D.
Pfeiffer, A.
机构：
[1] Ctr Salud La Calzada II, Gijon, Spain
[2] Hosp Son Dureta, Palma de Mallorca, Spain
[3] Merck Sharp & Dohme Espana SA, Outcomes Res & Pricing Support, Madrid, Spain
[4] Charite Univ Med Berlin, Sch Med, Berlin, Germany
来源：
DIABETOLOGIA | 2007年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0329
引用
收藏
页码：S143 / S143
页数：1
相关论文
共 50 条
  • [1] Glycemic control goal attainment among type 2 diabetic patients who initiated oral combination therapy in Hungary
    Gyoergy, B.
    Hungarian, R. G.
    Nagy, L.
    Erdesz, D.
    Yin, D.
    Krishnarajah, G.
    VALUE IN HEALTH, 2007, 10 (06) : A253 - A253
  • [2] Role of Initial Combination Therapy on Goal Attainment among Patients with Type 2 Diabetes with High HbA1c
    Klok, Rogier M.
    Gulati, Tania
    Rajpathak, Swapnil
    Pal, Sampriti
    Yang, Lingfeng
    Bandyopadhyay, Ashmita
    Khunti, Kamlesh
    DIABETES, 2019, 68
  • [3] Troglitazone in combination with sulphonylurea improves glycaemic control in Type 2 diabetic patients inadequately controlled by sulphonylurea therapy alone
    Buysschaert, M
    Bobbioni, E
    Starkie, M
    Frith, L
    Van Gaal, L
    Somers, G
    Reynders, P
    Buysschaert, M
    Bouillon, R
    Johansen, J
    Gilehuus, RE
    Furuseth, K
    Hansen, AN
    Luhdbo, C
    Caldeira, J
    Saraiva, M
    Correa, N
    Medina, L
    Silva, JL
    Robertson, L
    Lourens, W
    Bonnici, F
    Distiller, L
    Ellis, G
    Gomez, F
    Golay, A
    Suter, S
    Harrower, ADB
    Rayman, G
    Shaw, I
    Simpson, HCR
    Johnston, C
    White, M
    Hepburn, DA
    Beer, SF
    Leatherdale, BA
    Coppack, S
    Hamill, JJ
    Fisher, BM
    DIABETIC MEDICINE, 1999, 16 (02) : 147 - 153
  • [4] Smoking cessation and glycaemic control in type 2 diabetic patients
    Iino, K
    Iwase, M
    Tsutsu, N
    Iida, M
    DIABETES OBESITY & METABOLISM, 2004, 6 (03): : 181 - 186
  • [5] Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia
    Alwhaibi, Monira
    Altoaimi, Maha
    AlRuthia, Yazed
    Meraya, Abdulkarim M.
    Balkhi, Bander
    Aldemerdash, Ahmed
    Alkofide, Hadeel
    Alhawassi, Tariq M.
    Alqasoumi, Abdulmajeed
    Kamal, Khalid M.
    PATIENT PREFERENCE AND ADHERENCE, 2019, 13 : 2111 - 2118
  • [6] Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices
    Corcillo, Antonella
    Pivin, Edward
    Lalubin, Fabrice
    Pitteloud, Nelly
    Burnier, Michel
    Zanchi, Anne
    SWISS MEDICAL WEEKLY, 2017, 147
  • [7] Comparison of Coagulation Profile in Type 2 Diabetic Patients with Good Glycaemic Control and Poor Glycaemic Control
    Sherin, Binia
    Ramamurthy, Bhuvanamha Devi
    Sudalaimuthu, Muthu
    Ganapathy, Shivashekar
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2020, 14 (07) : EC06 - EC08
  • [8] Efficacy of simvastatin therapy in attainment of LDL-C and TG goal levels in patients with type 2 diabetic dyslipidemia
    Dobs, Adrian
    Miller, Michael
    DeLucca, Paul T.
    Ramsey, Karen E.
    Tershakovec, Andrew M.
    Horn, Wendy
    JOURNAL OF CLINICAL LIPIDOLOGY, 2008, 2 (01) : 12 - 18
  • [9] A COMPARISON OF COSTS AMONG PATIENTS WITH TYPE 2 DIABETES WHO INITIATED THERAPY WITH EXENATIDE OR SITAGLIPTIN
    Lage, M. J.
    Misurski, D. A.
    Fabunmi, R.
    Boye, K. S.
    VALUE IN HEALTH, 2008, 11 (06) : A501 - A501
  • [10] The effect of glycaemic control in type 2 diabetic patients with subclinical hypothyroidism
    Fu, X.
    Xia, H.
    Mao, H.
    Zhao, S.
    Wang, Z.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (12): : 1453 - 1458
12345